(Q57602052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Jordi Rio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Mar Tintoré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Jaume Sastre Garriga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Xavier Montalban

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

2

Lisa F Barcellos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

11

Jorge R Oksenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

9

Stephen L Hauser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

7

Sergio E Baranzini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

4

Ann B Begovich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Pilar Casquero

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

194-201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Genetic basis for clinical expression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

High-resolution analysis of human Y-chromosome variation shows a sharp discontinuity and limited gene flow between northwestern Africa and the Iberian Peninsula

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Frequency of Multiple Sclerosis in Menorca, Balearic Islands, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Genetic epidemiology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

HLA associations with multiple sclerosis in the Canary Islands.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Long-term effect of IFNbeta1b treatment on the spontaneous and induced expression of IL-10 and TGFbeta1 in MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Diagnostic criteria for multiple sclerosis research involving multiply affected families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Identifying disease modifying genes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

A test for linkage and association in general pedigrees: the pedigree disequilibrium test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Treatment of multiple sclerosis: recent trials and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

PedCheck: a program for identification of genotype incompatibilities in linkage analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Multiple sclerosis: genomic rewards

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Prevalence of multiple sclerosis in the sanitary district of Calatayud, Northern Spain: is Spain a zone of high risk for this disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, northern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900215-1

7 January 2021

10.1016/S0165-5728(02)00215-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12225902%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference